Media
Press releases
Quotient Limited to Participate in the Raymond James Life Sciences and MedTech Conference
JERSEY, Channel Islands, June 05, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present at the inaugural Raymond James Life Sciences and MedTech Conference on Wednesday…
Quotient Limited Recaps Recent Milestone Achievement and Updates on the Initial Serological Disease Screening CE Mark Submission, planned 2019 US Field Trials and Reports Record Financial Results
JERSEY, Channel Islands, May 28, 2019 (GLOBE NEWSWIRE) -- Following the recent CE marking of its initial Immunohematology (IH) microarray, Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today provided an update on the status of its initial Serological Disease Screening (SDS…
Quotient Limited to Participate in the Jefferies 2019 Healthcare Conference
JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present at the Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019 at 8:30 a.m.…
Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug Administration (FDA) has approved the commercialization of seven additional blood bank reagents for…
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call
JERSEY, Channel Islands, May 14, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2019 will be released before market open on Tuesday, May 28, 2019.
Quotient Limited Receives European CE Mark for its Initial IH Microarray
JERSEY, Channel Islands, May 01, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced receipt of the CE Mark (Conformité Européenne) for its initial Immunohematology (IH) Microarray for…
Quotient Limited Announces Initial SDS EU Field Trial Performance Data for MosaiQ™
JERSEY, Channel Islands, April 24, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive EU field trial performance data for its initial MosaiQ™ Serological Disease Screening (SDS) Microarray.
Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference
JERSEY, Channel Islands, March 07, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11…
Quotient Limited to Host Investor Day and Ring Closing Bell at the NASDAQ on March 4, 2019
JERSEY, Channel Islands, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company will host an Investor Day on Monday, March 4, 2019 from 1:00pm – 3:00pm ET, in New York, NY. Following the Investor Day, the Company’s…
Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
JERSEY, Channel Islands, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that today announced that the Company’s Chief Executive Officer, Franz Walt, will present at the 8th Annual SVB Leerink Global Healthcare Conference on…